AI Article Synopsis
- Over 200,000 people in the U.S. are diagnosed with breast cancer each year, highlighting the need for effective treatment and prevention strategies.
- Despite the potential of biomarkers to improve outcomes, advancements in this area have been limited, leading to mixed results.
- In 2005, a conference organized by the National Breast Cancer Coalition Fund brought together various stakeholders to create a strategy focused on patient-centered research, resulting in principles and recommendations for biomarker development in breast cancer.
Article Abstract
Each year, over 200,000 people are diagnosed with breast cancer in the United States. Although the use of biomarkers has the potential to guide preventive interventions and improve survival and quality of life, there have been few successes and many disappointments. In November 2005, the National Breast Cancer Coalition Fund convened a conference aimed at developing a patient-centred, strategic approach to breast cancer biomarker research. The consumers, clinicians, researchers, industry representatives and US regulators who served on the consensus panel developed a set of principles and recommendations to guide the field and ensure that biomarker research results in clinically important applications.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/nrc2113 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!